Hardman Johnston Global Equity Sold Novo Nordisk (NVO) due to Weak Script Trends

finance.yahoo.com/news/hardman-johnston-global-equity-sold-132912317.html

In This Article:
In its first-quarter 2025 investor letter, Hardman Johnston Global Equity Strategy highlighted stocks such as Novo Nordisk A/S (NYSE:NVO). Novo Nordisk A/S (NYSE:NVO) engages in the research and development, manufacture, and distribution of pharmaceutical products. The…

This story appeared on finance.yahoo.com, 2025-06-30 13:29:12.
The Entire Business World on a Single Page. Free to Use →